.png "Eli Lilly Buys Ventyx for $1.2B, Expanding NLRP3 Drug Portfolio")
Eli Lilly buys Ventyx as it builds its infiltration in inflammation-related diseases. The Indianapolis-based pharma giant reported today that it has initiated into a final deal to acquire Ventyx Biosciences. Ventyx Biosciences is a San Diego...
Dr. Lal PathLabs Limited today announced the launch of the Sovaaka Diagnostic Experience Centre in Gurugram, marking a major step in the evolution of preventive healthcare in India. The launch was graced by Haryana Chief Minister Nayab Singh...
Abbott launches Libre Assist at CES 2026, a smart Libre app feature using AI and CGM data to guide meal choices and predict glucose impact for people with diabetes.
Biocon Ltd announced Tuesday that its unit Biocon Biologics oncology biosimilars will expand with three new cancer therapies aimed at strengthening its presence in the global oncology market. With a regulatory filing, the company announced that...
Lupin Ltd announced today that its subsidiary, Lupin Manufacturing Solutions has entered into a longterm agreement with PolyPeptide Group AG. The joint venture will strengthen the global peptide-based active pharmaceutical ingredients supply...
Sun Pharmaceutical Industries has secured a major win after the Ahmedabad bench of the Customs, Excise and Service Tax Appellate Tribunal granted Sun Pharma CESTAT relief by setting aside a Rs 39 crore excise duty demand raised by tax authorities...
Eli Lilly has entered into a huge collaboration with Nimbus Therapeutics to develop a new obesity pill. This action assists Lilly in its quest to get out of injectable weight-loss drugs. The transaction, which was announced today, is aimed at...
.jpeg "Dr Reddy's Launches Hevaxin Hepatitis E Vaccine In India")
Dr Reddy’s launches Hevaxin, India’s only DCGI-approved hepatitis E vaccine, offering long-term immunity and supporting national efforts to reduce liver disease burden.
The 3rd Edition of Pack.Nxt successfully concluded on 16 December 2025 at The Lalit, Mumbai, bringing together senior packaging leaders, brand owners, converters, policymakers, consultants, and technology enablers for a full day of honest conversatio
Wegovy pill is now available in the U.S., bringing proven GLP 1 weight loss science into a simple once daily tablet. Approved on December 22, 2025, this new option expands treatment choices for more than 100 million Americans living with obesity...
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")